MediPal Holdings Corporation
7459
주식 순위
#4249
Medipal Holdings Corporation, a Tokyo, Japan-based company founded in 1898,... Medipal Holdings Corporation, a Tokyo, Japan-based company founded in 1898, primarily specializes in the wholesale distribution of prescription pharmaceuticals throughout Japan. The firm procures a broad spectrum of healthcare products, including medical equipment, materials, and clinical diagnostic reagents, utilized across diagnostics, testing, treatment, and administration, often from the pre-symptomatic stage. It also offers contract-based post-marketing surveillance (PMS) services to manufacturers and strategically invests in products like orphan drugs. Beyond pharmaceuticals, Medipal Holdings diversifies its wholesale activities to encompass cosmetics, daily necessities, and over-the-counter medications. Its extensive product portfolio further includes animal health products for companion animals, raw materials for food processing in the agricultural, fisheries, and livestock sectors, along with livestock feed additives, various seasonings, veterinary medical equipment, packaging materials, and industrial chemicals. The company also provides a comprehensive suite of specialized services. These include conducting contract epidemiological and clinical studies, creating computerized databases for medical supplies and master product data for healthcare facilities, and offering health insurance claims reviews, medical coding dispatch, outsourcing, and remote education. Medipal's operations extend to life and non-life insurance agency services, cleaning management, the full management and operation of distribution centers, commissioned delivery, and worker dispatch. Additionally, it handles the planning, management, administration, and product/service development for its branded Class A health dispensing pharmacies. Serving an expansive client base, Medipal Holdings partners with hospitals, clinics, dispensing pharmacies, drugstores, home centers, convenience stores, supermarkets, discount stores, animal hospitals, livestock and fishery businesses, and processed food manufacturers. The company adopted its current name, Medipal Holdings Corporation in October 2009, having previously operated as Mediceo Paltac Holdings Co., Ltd.
주가
$20.55
시가총액
$3.73B
변동 (1일)
0.77%
변동 (1년)
22.26%
국가
JP
거래 MediPal Holdings Corporation (7459)
카테고리
Healthcare
MediPal Holdings Corporation (7459)의 영업이익률
October 2026 기준 영업이익률 TTM: 1.36%
MediPal Holdings Corporation의 최신 재무 보고서와 주가에 따르면 현재 영업이익률 (TTM)은 1.36%입니다. 2024년 말 기준 영업이익률은 1.33%였습니다.
MediPal Holdings Corporation의 영업이익률 기록 (2005 ~ 2026)
매년 말 영업이익률
| 연도 | 영업이익률 | 변화 |
|---|---|---|
| 2026 (TTM) | 1.36% | -9.93% |
| 2025 | 1.51% | 13.53% |
| 2024 | 1.33% | -8.90% |
| 2023 | 1.46% | 5.04% |
| 2022 | 1.39% | 15.83% |
| 2021 | 1.20% | -26.38% |
| 2020 | 1.63% | 3.82% |
| 2019 | 1.57% | 11.35% |
| 2018 | 1.41% | 9.30% |
| 2017 | 1.29% | -7.86% |
| 2016 | 1.40% | 22.81% |
| 2015 | 1.14% | -3.39% |
| 2014 | 1.18% | 16.83% |
| 2013 | 1.01% | 32.89% |
| 2012 | 0.76% | 49.02% |
| 2011 | 0.51% | -29.17% |
| 2010 | 0.72% | 30.91% |
| 2009 | 0.55% | -55.65% |
| 2008 | 1.24% | -3.13% |
| 2007 | 1.28% | 19.63% |
| 2006 | 1.07% | 62.12% |
| 2005 | 0.66% | 0.00% |
유사 기업 또는 경쟁사의 영업이익률
| 회사 | 영업이익률 | 영업이익률 차이 | 국가 |
|---|---|---|---|
| 1.62% | -98.81% |
US
|
|
| 0.00% | - |
US
|
|
| 1.03% | -99.24% |
US
|
|
| 0.00% | - |
US
|
|
| 9.21% | -93.23% |
AU
|
회사의 영업이익률이란?
영업이익률은 회사의 수익성을 평가하는 핵심 지표입니다. 높은 영업이익률은 일반적으로 긍정적으로 간주되며, 이는 회사가 제품이나 서비스를 생산 비용보다 훨씬 높은 가격에 판매할 수 있음을 보여줍니다. 영업이익률은 회사의 수익을 매출로 나누어 계산합니다.